Structure-based study on Lat1 published in Scientific Reports

28.10.2019

Rigorous sampling of docking poses unveils binding hypothesis for the halogenated ligands of L-type Amino acid Transporter 1 (LAT1)

October 21, 2019 - Scientific Reports published the great work of our alumnus Natesh Singh together with Bruno O. Villoutreix and Gerhard F. Ecker on L-type Amino acid Transporter 1 (LAT1).

 

Abstract

L-type Amino acid Transporter 1 (LAT1) plays a significant role in the growth and propagation of cancer cells by facilitating the cross-membrane transport of essential nutrients, and is an attractive drug target. Several halogen-containing L-phenylalanine-based ligands display high affinity and high selectivity for LAT1; nonetheless, their molecular mechanism of binding remains unclear. In this study, a combined in silico strategy consisting of homology modeling, molecular docking, and Quantum Mechanics-Molecular Mechanics (QM-MM) simulation was applied to elucidate the molecular basis of ligand binding in LAT1. First, a homology model of LAT1 based on the atomic structure of a prokaryotic homolog was constructed. Docking studies using a set of halogenated ligands allowed for deriving a binding hypothesis. Selected docking poses were subjected to QM-MM calculations to investigate the halogen interactions. Collectively, the results highlight the dual nature of the ligand-protein binding mode characterized by backbone hydrogen bond interactions of the amino acid moiety of the ligands and residues I63, S66, G67, F252, G255, as well as hydrophobic interactions of the ligand’s side chains with residues I139, I140, F252, G255, F402, W405. QM-MM optimizations indicated that the electrostatic interactions involving halogens contribute to the binding free energy. Importantly, our results are in good agreement with the recently unraveled cryo-Electron Microscopy structures of LAT1.

 

Continue reading Scientific Reports at nature.com

 


This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.

 More News

Project
 

The whole RISK-HUNT3R consortium convened in June in Helsinki for a truly energizing week, bringing together project members and stakeholders to shape...

News
 

In this interview in the course of the VITALITY project, Gerhard Ecker talks about the aim to reduce the number of animal experiments by doing early...

News
 

The AI4Health project, a joint initiative by Robimo GmbH, spin-off of the University of Vienna, and the Pharmacoinformatics Research Group led by...